Semaglutide structure
Semaglutide
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
Find 53 Related Holders
HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
BEIJING QL BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
YANGZHOU AURISCO PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
HYBIO PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
ZHEJIANG PEPTITES BIOTECH CO LTD
United States
United States
API Registration Country
API Active
ZYDUS WORLDWIDE DMCC
United States
United States
API Registration Country
API Active
Sun Pharmaceutical Industries Ltd
United States
United States
API Registration Country
API Active
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
SHENZHEN JYMED TECHNOLOGY CO LTD
United States
United States
API Registration Country
API Active
ALP PHARM BEIJING CO LTD
United States
United States
API Registration Country
API Active
Recommended Suppliers of Semaglutide
-
Dingwang Technology (Wuhan) Co., Ltd.
CN1 YR
Contact Supplier -
Changsha Caoquan Technology Co., Ltd.
CN1 YR
Contact Supplier -
QingDao NuoChenJian Technology Co.,LTD
CN1 YR
Contact Supplier -
hongbaibiologic
CN1 YR
Contact Supplier -
SYS Pharma Corp.
CN1 YR
Contact Supplier